옵션 체인은 다양한 행사가격과 만기일에 대한 CureVac의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 CureVac에 대한 시장 심리를 평가합니다..

CureVac (NASDAQ:CVAC) 주식, 옵션 체인

CureVac

CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

Large Cap

News

Health Care

General

CVAC

MRNA

NVAX

네바다의 한 낙농업자가 1월에 루이지애나 남자의 사망과 관련된 조류 독감 D1.1 변종에 양성 반응을 보였다고 CNN이 보도했다. 미국 질병통제예방센터(CDC)는 월요일에 초기 양성 반응을 확인하기 위해 작업 중이다.

네바다 남성에서 발견된 치명적인 조류 독감 변종: 주목해야 할 4가지 주식

CureVac NV

COEP

COEPTIS Launches COEP Venture Group To Invest In AI, RPA And AI Agent Startups

Reddit Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) reported better-than-expected fourth-quarter financial results after the <a href="https://www.benzinga.com/quote/RDDT/earnings">market close on Wednesday.</a>
Reddit reported fourth-quarter revenue of $427.71 million. It beat the consensus estimate of $405.26 million, according to Benzinga Pro. Fourth-quarter earnings of 36 cents per share, topped analyst estimates of 25 cents per share.
&#8220;It was another strong quarter as we accomplished exciting milestones across revenue and international growth,&#8221; said Steve Huffman, Co-Founder and CEO of Reddit. &#8220;However, what&#8217;s most exciting is still ahead. We&#8217;re focused on providing a best-in-class experience for finding community and trusted information, proving that Reddit is for everyone, everywhere.&#8221;
Reddit expects first-quarter revenue to be in the range of $360 million to $370 million versus estimates of $358.08 million. The company sees first-quarter adjusted EBITDA of $80 million to $90 million.
Reddit shares gained 1.3% to close at $216.47 on Wednesday.
These analysts made changes to their price targets on Reddit following earnings announcement.
<ul>
<li>Morgan Stanley analyst Brian Nowak maintained Reddit with an Overweight and raised the price target from $200 to $210.</li>
<li>Baird analyst Colin Sebastian maintained the stock with a Neutral and raised the price target from $160 to $185.</li>
<li>Needham analyst Laura Martin maintained Reddit with a Buy and raised the price target from $190 to $220.</li>
<li>B of A Securities analyst Justin Post maintained Reddit with a Neutral and raised the price target from $180 to $190.</li>
</ul>
Considering buying RDDT stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="590" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/13083922/image-119-1024x590.png" alt="" class="wp-image-781033" style="width:530px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/13083922/image-119-1024x590.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/13083922/image-119-300x173.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/13083922/image-119-768x442.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/13083922/image-119.png 1106w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next:
<ul>
<li> <a href="https://www.benzinga.com/trading-ideas/short-ideas/25/02/43655479/top-3-utilities-stocks-that-may-collapse-in-q1">Top 3 Utilities Stocks That May Collapse In Q1</a></li>
</ul>

Price Target

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

RDDT

Reddit Analysts Increase Their Forecasts After Strong Earnings

Truist Securities analyst David Macdonald maintains CVS Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) with a Buy and raises the price target from $60 to $76.

Truist Securities Maintains Buy on CVS Health, Raises Price Target to $76

Needham analyst Bernie McTernan reiterates AppLovin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>) from Hold to Hold.

Reiteration

Needham Reiterates Hold on AppLovinto Hold

NANO Nuclear Energy To Be Included In MSCI USA Index As Of Feb. 28

Buybacks

MATH

Metalpha Announces $5M Buyback Program

Earnings

Guidance

IRMD

Iradimed Expects 2025 Revenue Of $78M-$82M Versus Consensus Of $80.66M, With Adjusted EPS Of $1.71-$1.81 Versus Consensus Of $1.75

Himax Technologies, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIMX#NASDAQ">HIMX</a>) reported a fiscal fourth-quarter revenue growth of 4.2% year-on-year to $237.22 million, beating the <a href="https://www.benzinga.com/pressreleases/25/02/g43686425/himax-technologies-inc-reports-fourth-quarter-and-full-year-2024-financial-results-provides-first-" target="_blank" rel="noreferrer noopener">analyst consensus estimate of $221.09 million</a>. Net revenues of the Arm Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>) customer increased by 6.7% Q/Q, primarily driven by stronger order momentum across product lines.
Earnings per ADS was&nbsp;$0.14, beating the&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">analyst consensus estimate of $0.10</a>.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/25/02/43657079/ryder-q4-earnings-fleet-and-supply-chain-drive-performance-ceo-warns-of-freight-market-headwinds-modest-2025-growth" rel="noreferrer noopener">Ryder Q4 Earnings: Fleet and Supply Chain Drive Performance, CEO Warns of Freight Market Headwinds, Modest 2025 Growth</a>
The stock price climbed after the print.
The gross margin reached 30.5%, exceeding its guidance of flat to slightly up from 30.0% in the previous quarter and 30.3% in the same period last year.
Revenue from large display drivers was $25.0 million, a decrease of 18.6% Q/Q due to continued customer destocking after substantial second-quarter replenishment for shopping festivals and heightened price competition from Chinese peers.
Small and medium-sized display driver revenue was $166.8 million, an increase of 7.4% Q/Q, helped by stronger-than-expected sales in the automotive and tablet markets.
Revenue for non-driver business was $45.4 million, up 24.9% Q/Q, driven by a one-time ASIC Tcon product shipment to a leading projector customer and Tcon for monitor application.
Operating expenses for the quarter decreased 6.0% Y/Y to $49.2 million.
Operating income was $23.1 million compared to $16.7 million a year ago and the margin increased by 240 bps to 9.7%, primarily due to higher sales and gross margins. 
As of December 31, 2024, the company's inventories were $158.7 million, markedly lower than&nbsp;the $192.5 million they had in the previous quarter.
Himax held $224.6 million of cash, cash equivalents and other financial assets as of December 31, 2024. The company generated $35.4 million in operating cash flow, compared to a positive operating cash flow of $68.7 million a year ago.
CEO Jordan Wu recalled at CES in 2025, Himax showcased a wide range of innovative achievements, including automotive display technology, WiseEye AI and advanced optical technologies for AR/VR. The industry demonstrated growing enthusiasm for AR glasses. For AR glasses, Himax offers three critical technologies, namely LCoS microdisplay, WLO waveguide and ultralow power WiseEye AI.
Q1 Guidance:&nbsp;Himax expects net revenues to grow flat to 4.6% Y/Y&nbsp;vs. the estimate of $200.7 million and EPADS of $0.09–$0.11&nbsp;versus&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">the&nbsp;$0.080&nbsp;estimate</a>.
Price Action:&nbsp;HIMX stock is up 8.21% at $9.89 premarket at&nbsp;the last check Thursday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/25/02/43636975/tower-semiconductor-adapts-to-nvidias-architectural-shift-analyst-sees-growth-in-ai-optical-networks" target="_blank" rel="noreferrer noopener">Tower Semiconductor Adapts To Nvidia&#8217;s Architectural Shift, Analyst Sees Growth In AI Optical Networks</a></li>
</ul>
Photo: Shutterstock

HIMX

Himax Q4 Earnings: Beats Estimates, Automotive And AI Tech Drive Revenue, Raises Outlook

Truist Securities analyst Srikripa Devarakonda maintains Biogen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIIB#NASDAQ">BIIB</a>) with a Buy and lowers the price target from $220 to $210.

BIIB

Truist Securities Maintains Buy on Biogen, Lowers Price Target to $210

Iradimed Expects Q1 2025 Revenue Of $19.2M-$19.4M Versus Consensus Of $19.13M, With Adjusted EPS Of $0.39-$0.43 Versus Consensus Of $0.41

Focus on Patients with Elevated Markers of Heart Stress and Inflammation
Procedural enhancement using FDA Approved Morph DNA steerable guide for therapeutic delivery

Biotech

BCDA

BioCardia Completes Low Dose Cohort Enrollment For CardiALLO Phase I/II Clinical Trial Of BCDA-03 Allogeneic Mesenchymal Stem Cells

HC Wainwright &amp; Co. analyst Raghuram Selvaraju reiterates BridgeBio Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBIO#NASDAQ">BBIO</a>) with a Buy and maintains $49 price target.

BBIO

HC Wainwright & Co. Reiterates Buy on BridgeBio Pharma, Maintains $49 Price Target

Contracts

BlackSky Technology Inc. Class A Common Stock

BKSY

BlackSky Announces Multi-Year Contracts  With Combined Value Of Eight Figures

Editor&#8217;s Note: This article has been updated to include additional details.
Tesla Inc. CEO and billionaire Elon Musk has proposed an extreme spending cut and restructuring initiative for the U.S., suggesting the deletion of entire agencies.
What Happened: During&nbsp;a video call to the World&nbsp;Governments Summit hosted by the United Arab Emirates' Artificial Intelligence Minister Omar Sultan Al Olama in Dubai, Musk stated "I think we do need to delete entire agencies, as opposed to leave part of them behind &#8230; It's kind of like leaving a weed." 
He then likened the situation to weeds, saying that merely cutting them back allows them to regrow easily. However, removing the roots doesn't guarantee they'll never return, but it significantly reduces the chances of them growing back, reported the <a href="https://apnews.com/article/elon-musk-doge-us-uae-6f7c0e5b43adfb4ec3c1f14a964f573c">AP News</a>&nbsp;on Thursday.
In addition, he discussed the Trump administration&#8217;s priorities, frequently mentioning &#8220;thermonuclear warfare&#8221; and potential artificial intelligence dangers.
With President Donald Trump&#8216;s approval, Musk, who now leads the Department of Government Efficiency (DOGE), criticized the bureaucracy&#8217;s dominance over democracy. He took a more isolationist approach to American influence in the Middle East, stating that under Trump, the U.S. is &#8220;less interested in interfering with the affairs of other countries.&#8221;
Musk&#8217;s remarks follow Trump&#8217;s recent announcement that the<a href="https://www.benzinga.com/25/02/43484176/trump-says-us-will-take-over-gaza-strip-were-going-to-develop-it-create-thousands-of-jobs"> U.S. plans to take control of the Gaza Strip</a> and invest in its economic development after relocating Palestinians. The president also reaffirmed this stance during a White House meeting with Jordan's King Abdullah. &#8220;<a href="https://in.benzinga.com/news/25/02/43637482/trump-gaza-cherish-it-white-house-meeting-with-jordans-king-abdullah">We are going to take it</a> and cherish it," Trump said.
SEE ALSO: <a href="https://www.benzinga.com/25/02/43686887/teslas-stock-climbs-nearly-3-in-thursday-pre-market-as-analyst-predicts-growth-in-ev-ai-and-robotics">Tesla Stock Climbs Over 2% In Thursday Pre-Market: What&#8217;s Going On?</a>
Why It Matters: Musk&#8217;s call for radical spending cuts comes amid increased scrutiny of politicians&#8217; stock and options trading activity. Earlier, Musk had questioned the <a href="https://www.benzinga.com/politics/25/02/43663526/elon-musk-questions-congress-members-wealth-where-did-they-get-all-the-money">wealth of Congress members</a>. He pointed out that members of Congress could trade stocks, options, and cryptocurrencies, provided they disclose the transactions timely. This trading activity has raised conflict of interest concerns, as it often appears to be based on non-public knowledge and sometimes involves stocks related to government-funded contracts.
On Tuesday, Elon Musk also made an appearance at the White House standing alongside President Trump to address the media. Musk described DOGE's work as "common sense" and "not draconian or radical." He also said that they've found "shocking" proofs of wasteful expenditure and defended the extensive spending cuts.
In the video call, Musk also unveiled plans for a &#8220;Dubai Loop&#8221; project, related to the tunnel-digging project in Las Vegas with the Boring Company. However, no immediate details were provided.
Regarding AI, Musk stated that he expects X's newly updated AI chatbot, Grok 3, to be ready in approximately two weeks, calling it "kind of scary." He also criticized Sam Altman's OpenAI comparing it to a <a href="https://www.benzinga.com/media/25/02/43646042/elon-musks-97-4-billion-openai-takeover-bid-reportedly-not-received-by-chatgpt-parent-another-one-of-his-tactics-says-sam-altman">non-profit dedicated</a> to protecting the Amazon rainforest turning into "lumber company that chops down the trees."
The shares of Elon Musk&#8217;s Tesla have been on a decline since President Trump&#8217;s inauguration, and after Musk officially joined the DOGE. Tesla stock tumbled over 16% over the past month.
<ul>
<li>READ MORE:<a href="https://apnews.com/article/trump-downsizing-federal-workers-doge-00683abc4de44a151f26aaa6cb0d0f30"> Super Micro Rides AI Server Boom, Analysts See Big 2026 Growth Despite Near-Term Challenges</a></li>
</ul>
Image Via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Tech

TSLA

Elon Musk Urges Trump To 'Delete Entire Agencies' As DOGE Lead Calls For Radical US Spending Cuts: 'Remove The Roots Of The Weeds' (UPDATED)

WTER

The Alkaline Water Signs Letter Of Intent With FA Note Buyers For Proposed Acquisition Fulfilled Through Issuance Of 34M Shares Subject To 12 Month Lockup Period

Truist Securities analyst Mark Hughes maintains Assurant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIZ#NYSE">AIZ</a>) with a Buy and raises the price target from $240 to $250.

Truist Securities Maintains Buy on Assurant, Raises Price Target to $250

Barclays analyst David Anderson maintains Weatherford International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WFRD#NASDAQ">WFRD</a>) with a Overweight and lowers the price target from $100 to $92.

WFRD

Barclays Maintains Overweight on Weatherford International, Lowers Price Target to $92

Market Index Target Term Securities Linked To The Dow Jones Industrial Average

SunCar Technology Expands Partnership With A 'Foremost Electric Vehicle Manufacturer;' Terms Not Disclosed

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Needham raised Reddit, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) price target from $190 to $220. Needham analyst Laura Martin maintained a Buy rating. Fidelity National In Reddit formation shares closed at $216.47 on Wednesday. See how other analysts view this stock.</li>
<li>Barclays raised the price target for Mr. Cooper Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COOP#NYSE">COOP</a>) from $111 to $130. Barclays analyst Terry Ma maintained an Overweight rating. Mr. Cooper shares closed at $106.71 on Tuesday. See how other analysts view this stock.</li>
<li>Baird slashed The Trade Desk, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTD#NASDAQ">TTD</a>) price target from $160 to $145. Baird analyst Vikram Kesavabhotla maintained an Outperform rating. Lyft shares closed at $122.23 on Wednesday. See how other analysts view this stock.</li>
<li>HC Wainwright &amp; Co. cut the price target for Cybin Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CYBN#NYSE">CYBN</a>) from $190 to $150. HC Wainwright &amp; Co. analyst Patrick Trucchio maintained a Buy rating. Cybin shares closed at $9.36 on Wednesday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Leerink Partners cut the price target for 10x Genomics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXG#NASDAQ">TXG</a>) from $25 to $12. Leerink Partners analyst Mike Kratky downgraded the stock from Outperform to Market Perform. 10x Genomics shares closed at $12.00 on Wednesday. See how other analysts view this stock.</li>
<li>Morgan Stanley cut Cytokinetics, Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYTK#NASDAQ">CYTK</a>) price target from $70 to $67. Morgan Stanley analyst Jeffrey Hung upgraded the stock from Equal-Weight to Overweight. Cytokinetics shares settled at $42.18 on Wednesday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Mizuho increased MGM Resorts International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MGM#NYSE">MGM</a>) price target from $56 to $60. Mizuho analyst Ben Chaiken maintained an Outperform rating. MGM shares closed at $34.37 on Wednesday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Canaccord Genuity raised HubSpot, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUBS#NYSE">HUBS</a>) price target from $710 to $900. Canaccord Genuity analyst David Hynes maintained a Buy rating. HubSpot shares closed at $785.50 on Wednesday.  <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wedbush raised the price target for Dutch Bros Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BROS#NYSE">BROS</a>) from $65 to $100. Wedbush analyst Nick Setyan maintained an Outperform rating. Dutch Bros shares settled at $64.71 on Wednesday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays increased Cisco Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>) price target from $56 to $61. Barclays analyst Tim Long maintained an Equal-Weight rating. Cisco shares closed at $62.53 on Wednesday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/02/43655479/top-3-utilities-stocks-that-may-collapse-in-q1">Top 3 Utilities Stocks That May Collapse In Q1</a></li>
</ul>

BROS

COOP

CSCO

CYBN

CYTK

HUBS

MGM Resorts To Rally Around 75%? Here Are 10 Top Analyst Forecasts For Thursday

Tempus Collaborates With IFLI Aimed For Development Of  Targeted Therapies for Follicular Lymphoma Patients

Leerink Partners analyst Mani Foroohar maintained a Hold rating on CureVac (CVAC – Research Report) on November 12. The company's shares closed yes...

Leerink Partners Sticks to Their Hold Rating for CureVac (CVAC)

Analyst Roy Buchanan of JMP Securities reiterated a Buy rating on CureVac (CVAC – Research Report), retaining the price target of $16.00. Roy Bucha...

CureVac: Strong Financial Position and Promising Pipeline Justify Buy Rating

California Gov. Newsom declares State of Emergency over bird flu

Vaccine stocks gain amid uptick in flu, COVID-19, RSV

Bird flu claims first U.S. life in Louisiana

Shares of Moderna (MRNA), one of a few drugmakers currently developing a vaccine for the H5N1 bird flu, were up nearly 10% in early trading after t...

Bird flu vaccine maker Moderna shares jump after first US death, Barron's says

Moderna, Novavax and other vaccine names extend gains amid COVID/flu concerns

Arbutus could benefit from Big Pharma bird flu vaccines: Jefferies

CureVac: Latest GBM Data Bodes Well For Next Program Check Point

Bird flu reaches NYC as live poultry markets shut down

ABUS

ARCT

BNTX

CSLLY

GLAXF

ROIV

Press Releases

CureVac Advances Cancer Vaccine Candidate CVGBM to Part B of Phase 1 Study in Patients with Resected Glioblastoma

CureVac Announces Financial Results for the Second Quarter and First Half of 2024 and Provides Business Update

CureVac to Present First CVGBM Glioblastoma Cancer Vaccine Clinical Data at ESMO 2024 Congress

CureVac Partner GSK Announces Positive Phase 2 Data from Seasonal Influenza  mRNA Vaccine Program

CureVac's CVGBM Cancer Vaccine Induces Promising Immune Responses in Phase 1 Study in Glioblastoma Presented at the ESMO 2024 Congress

Events

CureVac to Present at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting

CureVac to Present at the 12th International mRNA Health Conference

Management

CureVac Strengthens Leadership Team with Appointment of Seasoned Industry Executive Axel Sven Malkomes as Chief Financial Officer

CureVac to Report Third Quarter and First Nine Months 2024 Financial Results and Business Update on November 12, 2024

CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2024 and Provides Business Update

JMP Securities

Leerink Partners

B of A Securities

SVB Securities

Comments

CureVac

CureVac (CVAC) 옵션

CureVac (NASDAQ:CVAC) 주식, 옵션 체인

뉴스

파트너 / 기고자

벤징가 글로벌